| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.009 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |